1,25-Dihydroxyvitamin/NN
D3/NN
induces/VBZ
differentiation/NN
of/IN
a/DT
retinoic/JJ
acid-resistant/JJ
acute/JJ
promyelocytic/JJ
leukemia/NN
cell/NN
line/NN
(/(
UF-1/NN
)/)
associated/VBN
with/IN
expression/NN
of/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
p27/NN
(/(
KIP1/NN
)/)
./.

Retinoic/JJ
acid/NN
(/(
RA/NN
)/)
resistance/NN
is/VBZ
a/DT
serious/JJ
problem/NN
for/IN
patients/NNS
with/IN
acute/JJ
promyelocytic/JJ
leukemia/NN
(/(
APL/NN
)/)
who/WP
are/VBP
receiving/VBG
all-trans/JJ
RA/NN
./.
=====
However/RB
,/,
the/DT
mechanisms/NNS
and/CC
strategies/NNS
to/TO
overcome/VB
RA/NN
resistance/NN
by/IN
APL/NN
cells/NNS
are/VBP
still/RB
unclear/JJ
./.
=====
The/DT
biologic/JJ
effects/NNS
of/IN
RA/NN
are/VBP
mediated/VBN
by/IN
two/CD
distinct/JJ
families/NNS
of/IN
transcriptional/JJ
factors/NNS
:/:
RA/NN
receptors/NNS
(/(
RARs/NNS
)/)
and/CC
retinoid/NN
X/NN
receptors/NNS
(/(
RXRs/NNS
)/)
./.
=====
RXRs/NNS
heterodimerize/VBP
with/IN
1, 25-dihydroxyvitamin/NN
D3/NN
[/(
1,25(OH)2D3/NN
]/)
receptor/NN
(/(
VDR/NN
)/)
,/,
enabling/VBG
their/PRP$
efficient/JJ
transcriptional/JJ
activation/NN
./.
=====
The/DT
cyclin-dependent/JJ
kinase/NN
(/(
cdk/NN
)/)
inhibitor/NN
p21/NN
(/(
WAF1/CIP1/NN
)/)
has/VBZ
a/DT
vitamin/NN
D3-responsive/JJ
element/NN
(/(
VDRE/NN
)/)
in/IN
its/PRP$
promoter/NN
,/,
and/CC
1,25(OH)2D3/NN
enhances/VBZ
the/DT
expression/NN
of/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
induces/VBZ
differentiation/NN
of/IN
selected/VBN
myeloid/JJ
leukemic/JJ
cell/NN
lines/NNS
./.
=====
We/PRP
have/VBP
recently/RB
established/VBN
a/DT
novel/JJ
APL/NN
cell/NN
line/NN
(/(
UF-1/NN
)/)
with/IN
features/NNS
of/IN
RA/NN
resistance/NN
./.
=====
1,25(OH)2D3/NN
can/MD
induce/VB
growth/NN
inhibition/NN
and/CC
G1/NN
arrest/NN
of/IN
UF-1/NN
cells/NNS
,/,
resulting/VBG
in/IN
differentiation/NN
of/IN
these/DT
cells/NNS
toward/IN
granulocytes/NNS
./.
=====
This/DT
1, 25(OH)2D3-induced/JJ
G1/NN
arrest/NN
is/VBZ
enhanced/VBN
by/IN
all-trans/JJ
RA/NN
./.
=====
Also/RB
,/,
1, 25(OH)2D3/NN
(/(
10(-10)/CD
to/TO
10(-7)/CD
mol/L/NN
)/)
in/IN
combination/NN
with/IN
RA/NN
markedly/RB
inhibits/VBZ
cellular/JJ
proliferation/NN
in/IN
a/DT
dose-/NN
and/CC
time-dependent/JJ
manner/NN
./.
=====
Associated/VBN
with/IN
these/DT
findings/NNS
,/,
the/DT
levels/NNS
of/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
p27/NN
(/(
KIP1/NN
)/)
mRNA/NN
and/CC
protein/NN
increased/VBD
in/IN
these/DT
cells/NNS
./.
=====
Northern/NN
blot/NN
analysis/NN
showed/VBD
that/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
p27/NN
(/(
KIP1/NN
)/)
mRNA/NN
and/CC
protein/NN
increased/VBD
in/IN
these/DT
cells/NNS
./.
=====
Northern/NN
blot/NN
analysis/NN
showed/VBD
that/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
p27/NN
(/(
KIP1/NN
)/)
transcripts/NNS
were/VBD
induced/VBN
after/IN
6/CD
hours/NNS
'/POS
exposure/NN
to/TO
1,25(OH)2D3/NN
and/CC
then/RB
decreased/VBD
to/TO
basal/JJ
levels/NNS
over/IN
48/CD
hours/NNS
./.
=====
Western/NN
blot/NN
experiments/NNS
showed/VBD
that/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
protein/NN
levels/NNS
increased/VBD
and/CC
became/VBD
detectable/JJ
after/IN
12/CD
hours/NNS
of/IN
1,25(OH)2D3/NN
treatment/NN
and/CC
induction/NN
of/IN
p27/NN
(/(
KIP1/NN
)/)
protein/NN
was/VBD
much/RB
more/RBR
gradual/JJ
and/CC
sustained/JJ
in/IN
UF-1/NN
cells/NNS
./.
=====
Interestingly/RB
,/,
the/DT
combination/NN
of/IN
1, 25(OH)2D3/NN
and/CC
RA/NN
markedly/RB
enhanced/VBD
the/DT
levels/NNS
of/IN
p27/NN
(/(
KIP1/NN
)/)
transcript/NN
and/CC
protein/NN
as/IN
compared/VBN
with/IN
levels/NNS
induced/VBN
by/IN
1, 25(OH)2D3/NN
alone/RB
./.
=====
In/IN
addition/NN
,/,
exogenous/JJ
p27/NN
(/(
KIP1/NN
)/)
expression/NN
can/MD
enhance/VB
the/DT
level/NN
of/IN
CD11b/NN
antigen/NN
in/IN
myeloid/JJ
leukemic/JJ
cells/NNS
./.
=====
In/IN
contrast/NN
,/,
RA/NN
alone/RB
can/MD
induce/VB
G1/NN
arrest/NN
of/IN
UF-1/NN
cells/NNS
;/:
however/RB
,/,
it/PRP
did/VBD
not/RB
result/VB
in/IN
an/DT
increase/NN
of/IN
p21/NN
(/(
WAF1/CIP1/NN
)/)
and/CC
p27/NN
(/(
KIP1/NN
)/)
transcript/NN
and/CC
protein/NN
expression/NN
in/IN
RA-resistant/JJ
cells/NNS
./.
=====
Taken/VBN
together/RB
,/,
we/PRP
conclude/VBP
that/IN
1,25(OH)2D3/NN
induces/VBZ
increased/VBN
expression/NN
of/IN
cdk/NN
inhibitors/NNS
,/,
which/WDT
mediates/VBZ
a/DT
G1/NN
arrest/NN
,/,
and/CC
this/DT
may/MD
be/VB
associated/VBN
with/IN
differentiation/NN
of/IN
RA-resistant/JJ
UF-1/NN
cells/NNS
toward/IN
mature/JJ
granulocytes/NNS
./.